Wednesday, September 10, 2014 10:00:02 AM
Primarily because you never comment on much positives about the company.
Had it not been for the FDA mess with Lovenox and subsequent mess by the courts re MNTA patent/FDA disclosure of proprietary info - MNTA would have enjoyed additional revenue for a while.
Copaxone approval - 99.9% in my opinion, imminent launch.
This should carry the company until additional revenue is generated with Baxter and advancement of pipeline.
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM